SCHEMBL16966151

SCHEMBL16966151

COCCNC1CCc2ccc(Nc3ncc(Cl)c(N[C@H]4[C@@H](OC(N)=O)[C@@H]5C=C[C@H]4C5)n3)c(OC)c2CC1

nearest known ligand 0.83

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 20/20 0.83
INSR P06213 12/20 0.70
PTK2 Q05397 5/20 0.60
NUAK1 O60285 1/20 0.60
CHEK2 O96017 1/20 0.60
FES P07332 1/20 0.60
FER P16591 1/20 0.60
FLT4 P35916 1/20 0.60
FLT3 P36888 1/20 0.60
MAPK8 P45983 1/20 0.60
RPS6KA3 P51812 1/20 0.60
TNK2 Q07912 1/20 0.60
MAP4K2 Q12851 1/20 0.60
PTK6 Q13882 1/20 0.60
RPS6KA2 Q15349 1/20 0.60
RPS6KA1 Q15418 1/20 0.60
RPS6KA6 Q9UK32 1/20 0.60
KCNH2 Q12809 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16966101 0.95 ALK (0.74) ALKINSRPTK2NUAK1CHEK2
SCHEMBL16965983 0.92 ALK (0.84) ALKINSRPTK2NUAK1CHEK2
SCHEMBL16966125 0.91 ALK (0.69) ALKINSRPTK2NUAK1CHEK2
SCHEMBL2061872 0.91 ALK (1.00) ALKINSRPTK2NUAK1CHEK2
SCHEMBL16966015 0.89 ALK (0.66) ALKINSRPTK2NUAK1CHEK2
SCHEMBL16966110 0.88 ALK (0.82) ALKINSRPTK2NUAK1CHEK2
SCHEMBL16966260 0.87 ALK (0.77) ALKINSRPTK2NUAK1CHEK2
SCHEMBL16965965 0.86 ALK (0.61) ALKINSRPTK2NUAK1CHEK2
SCHEMBL16966022 0.85 ALK (0.83) ALKINSRPTK2NUAK1CHEK2
SCHEMBL2061967 0.85 ALK (0.90) ALKINSRPTK2NUAK1CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2684874-B1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and C-met inhibitors CEPHALON INC (US) 2017-05-17 EP claimed
EP-2222647-B1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS CEPHALON INC (US) 2015-08-05 EP claimed